Picture of Amphastar Pharmaceuticals, logo

AMPH Amphastar Pharmaceuticals, News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapContrarian

U.S. RESEARCH ROUNDUP- Avalara, Global Blood Therapeutics, Tyson Foods

Aug 9 (Reuters) - Wall Street securities analysts revised their ratings and price targets on
several U.S.-listed companies, including Avalara, Global Blood Therapeutics and Tyson Foods on
Tuesday. 
    
  HIGHLIGHTS        
     * Avalara Inc  AVLR.N : Needham cuts to hold from buy
     * Global Blood Therapeutics Inc  GBT.O : Oppenheimer cuts to perform from outperform
     * Tyson Foods Inc  TSN.N : Piper Sandler raises to neutral from underweight
                
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order.        
     * 10X Genomics Inc  TXG.O : JP Morgan cuts target price to $65 from $100
     * Aaon Inc  AAON.O : D.A. Davidson raises target price to $72 from $70
     * Acadia Pharmaceuticals Inc  ACAD.O : SVB Securities cuts target price to $21 from $27
     * Akoya Biosciences Inc  AKYA.O : JP Morgan raises target price to $22 from $20
     * Allbirds Inc  BIRD.O : Piper Sandler cuts target price to $8 from $10
     * Allovir Inc  ALVR.O : JP Morgan cuts target price to $25 from $32
     * ALX Oncology Holdings Inc  ALXO.O : Credit Suisse cuts target price to $38 from $43
     * Amphastar Pharmaceuticals Inc  AMPH.O : Piper Sandler cuts target price to $43 from $45
     * Apellis Pharmaceuticals Inc  APLS.O : Credit Suisse raises target price to $52 from $49
     * Atea Pharmaceuticals Inc  AVIR.O : JP Morgan raises target price to $12 from $11
     * Avalara Inc  AVLR.N : Needham cuts to hold from buy
     * Avalara Inc  AVLR.N : Piper Sandler cuts target price to $93.5 from $118
     * Avalara Inc  AVLR.N : Piper Sandler cuts to neutral from overweight
     * Brightview Holdings Inc  BV.N : JP Morgan cuts target price to $10 from $13
     * Cargurus Inc  CARG.O : BTIG cuts target price to $30 from $33
     * Cargurus Inc  CARG.O : Jefferies cuts target price to $32 from $35
     * Cargurus Inc  CARG.O : RBC cuts target price to $35 from $45
     * Castle Biosciences Inc  CSTL.O : SVB Securities raises target price to $50 from $45
     * Celldex Therapeutics Inc  CLDX.O : SVB Securities cuts target price to $64 from $68
     * Choice Hotels International Inc  CHH.N : JP Morgan cuts target price to $110 from $126
     * Cincor pharma Inc  CINC.O : Oppenheimer raises target price to $60 from $35
     * Clover Health Investments Corp  CLOV.O : Credit Suisse cuts target price to $3 from $3.5
     * Coastal Financial Corp (Everett)  CCB.O : Stephens raises target price to $56 from $52
     * Crispr Therapeutics AG  CRSP.O : Chardan Capital Markets cuts PT to $154 from $164
     * Curo Group Holdings Corp  CURO.N : Credit Suisse cuts target price to $14 from $15
     * Deciphera Pharmaceuticals Inc  DCPH.O : Jonestrading raises target price to $10 from $6
     * Digital Turbine Inc  APPS.O : Oppenheimer cuts target price to $32 from $40
     * Digitalocean Holdings Inc  DOCN.N : Oppenheimer cuts target price to $65 from $80
     * Digitalocean Holdings Inc  DOCN.N : Piper Sandler raises target price to $57 from $56
     * Ehealth Inc  EHTH.O : RBC cuts target price to $16 from $17
     * Elanco Animal Health Inc  ELAN.N : JP Morgan cuts target price to $28 from $32
     * Energizer Holdings Inc  ENR.N : JP Morgan cuts target price to $32 from $33
     * Evercommerce Inc  EVCM.O : JP Morgan cuts target price to $17 from $18
     * Global Blood Therapeutics Inc  GBT.O : Oppenheimer cuts to perform from outperform
     * Global Blood Therapeutics Inc  GBT.O : Truist Securities cuts to hold from buy
     * Global Blood Therapeutics Inc  GBT.O : Truist Securities raises target to $68.5 from $50
     * Global Blood Therapeutics Inc  GBT.O : Wedbush cuts to neutral from outperform
     * Global Blood Therapeutics Inc  GBT.O : Wedbush cuts target price to $68.5 from $74
     * Global Blood Therapeutics Inc  GBT.O : Wedbush removes stock from its best ideas list
     * Goodrx Holdings Inc  GDRX.O : Credit Suisse raises target price to $11 from $10
     * Heska Corp  HSKA.O : JP Morgan cuts target price to $175 from $190
     * Huntsman Corp  HUN.N : JP Morgan cuts target price to $30 from $34
     * Inhibrx Inc  INBX.O : Credit Suisse cuts target price to $48 from $53
     * Inspirato Inc  ISPO.O : Piper Sandler cuts target price to $7 from $9
     * International Money Express Inc  IMXI.O : Credit Suisse raises target to $23 from $21.5
     * Iron Mountain Inc  IRM.N : JP Morgan cuts target price to $58 from $60
     * Kaleyra Inc  KLR.N : Oppenheimer cuts target price to $6 from $10
     * Karuna Therapeutics Inc  KRTX.O : Mizuho raises target price to $276 from $190
     * Karuna Therapeutics Inc  KRTX.O : Oppenheimer raises target price to $285 from $175
     * Karuna Therapeutics Inc  KRTX.O : SVB Securities raises target price to $270 from $170
     * Kodiak Sciences Inc  KOD.O : Truist Securities raises target price to $15 from $10
     * Krystal Biotech Inc  KRYS.O : Chardan Capital Markets cuts target price to $130 from $137
     * Luminar  LAZR.O : Jefferies cuts target price to $14 from $17
     * Mersana Therapeutics Inc  MRSN.O : Baird raises target price to $20 from $18
     * Mersana Therapeutics Inc  MRSN.O : SVB Securities raises target price to $14 from $13
     * Natura & Co Holding SA  NTCO.N : JP Morgan cuts target price to $7 from $8.5
     * Novavax Inc  NVAX.O : Cowen and Company cuts target price to $110 from $150
     * Nvidia Corp  NVDA.O : JP Morgan cuts target price to $230 from $285
     * Nvidia Corp  NVDA.O : Oppenheimer cuts target price to $250 from $300
     * Nvidia Corp  NVDA.O : Susquehanna cuts target price to $210 from $220
     * Nyxoah SA  NYXH.O : Piper Sandler cuts target price to $20 from $30
     * One Liberty Properties Inc  OLP.N : Colliers Securities cuts target price by $2 to $28
     * Owens & Minor Inc  OMI.N : JP Morgan cuts target price to $35 from $43
     * Palantir Technologies Inc  PLTR.N : Credit Suisse cuts target price to $11 from $12
     * Penn Entertainment Inc  PENN.O : Jefferies raises target price to $50 from $48
     * Piedmont Office Realty Trust Inc  PDM.N : JP Morgan cuts target price to $17 from $19
     * Playags Inc  AGS.N : Jefferies raises target price to $6 from $5.5
     * Powerschool Holdings Inc  PWSC.N : Piper Sandler raises target price to $19 from $15
     * Precision Biosciences Inc  DTIL.O : Jefferies cuts target price to $12 from $17
     * Pubmatic Inc  PUBM.O : Jefferies raises target price to $21 from $20
     * Pubmatic Inc  PUBM.O : Oppenheimer cuts target price to $28 from $30
     * Puretech Health  PRTC.O : SVB Securities raises target price to $70 from $66
     * Qualys Inc  QLYS.O : RBC raises target price to $148 from $145
     * Rxsight Inc  RXST.O : JP Morgan raises target price to $17 from $15
     * Ryman Hospitality Properties Inc  RHP.N : JP Morgan raises target price to $85 from $83
     * Syndax Pharmaceuticals Inc  SNDX.O : Baird raises target price to $32 from $29
     * Take-Two Interactive Software Inc  TTWO.O : Credit Suisse cuts PT to $137 from $139
     * Treehouse Foods Inc  THS.N : Credit Suisse raises target price to $45 from $40
     * Trex Company Inc  TREX.N : Barclays cuts target price to $53 from $63
     * Trex Company Inc  TREX.N : Truist Securities cuts target price to $85 from $90
     * Tyson Foods Inc  TSN.N : Bernstein cuts target price to $101 from $105
     * Tyson Foods Inc  TSN.N : JP Morgan cuts target price to $85 from $89
     * Tyson Foods Inc  TSN.N : Piper Sandler raises to neutral from underweight
     * Uniqure NV  QURE.O : Chardan Capital Markets cuts target price to $60 from $65
     * Unum Group  UNM.N : Jefferies raises target price to $37 from $34
     * Upstart Holdings Inc  UPST.O : Piper Sandler cuts target price to $24 from $25
     * Vivint Smart Home Inc  VVNT.N : JP Morgan cuts target price to $9 from $10
     * Whirlpool Corp  WHR.N : JP Morgan cuts target price to $188 from $191
 
    

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))

Recent news on Amphastar Pharmaceuticals,

See all news